1 year return (CAGR)
116.47%
Aeglea Bio Therapeutics Inc Exchange (NASDAQ, USD)
AGLE
-
-0.06 (-0.22%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-45.84%
5 year return (CAGR)
-33.53%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
111.75M
Price/Sales
106.03
Ent value
473.83M
Price/Book
-
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 26.71 |
| Daily high | 28.09 |
| Daily low | 26.60 |
| Daily Volume | 411K |
| 1y analyst estimate | 17.50 |
| Beta | 2.57 |
| EPS (TTM) | -68.57 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AGLE | S&P500 | |
| Current price drop from All-time high | -90.79% | -0.08% |
| Highest price drop | -99.11% | -56.47% |
| Date of highest drop | 21 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -54.45% | -10.68% |
| Avg time to new high | 1966 days | 12 days |
| Max time to new high | 1965 days | 1805 days |
News
No items found